Valuation : DRI Healthcare Trust

Market Cap 691M 594M 560M 510M 954M 65.73B 958M 6.63B 2.56B 33.49B 2.59B 2.54B 106B P/E 2026 *
22.5x
P/E 2027 * 22.4x
Enterprise Value 932M 802M 755M 688M 1.29B 88.66B 1.29B 8.95B 3.46B 45.17B 3.5B 3.42B 143B EV / Sales 2026 *
4.85x
EV / Sales 2027 * 4.82x
Free-Float
99.76%
Yield 2026 *
3.42%
Yield 2027 * 3.6%
1 day-0.17%
1 week-1.70%
Current month-0.52%
1 month-1.53%
3 months-7.51%
6 months+3.95%
Current year+8.03%
1 week 16.9
Extreme 16.9
17.75
1 month 16.9
Extreme 16.9
19.18
Current year 15
Extreme 15
19.75
1 year 14.1
Extreme 14.1
19.75
3 years 10.21
Extreme 10.21
19.75
5 years 5.83
Extreme 5.83
19.75
10 years 5.83
Extreme 5.83
19.75
Manager TitleAgeSince
Chief Executive Officer 51 2020-05-31
Director of Finance/CFO - 2025-09-30
Chief Tech/Sci/R&D Officer - 2014-08-31
Director TitleAgeSince
Chairman 63 2021-01-21
Director/Board Member 51 2020-05-31
Director/Board Member 66 2021-01-21
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 Option

Chairman

-3,008 0.0055%
9/1/26 Option

Chairman

1,397 0.0025%
9/1/26 Option

Chairman

1,397 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
-0.17%-1.70%+18.90%+44.19% 694M
+0.03%-3.09%+49.77%+91.69% 1,002B
-0.76%-2.95%+50.93%+66.34% 649B
+0.86%-4.13%+19.24%+68.37% 440B
-0.80%-0.43%+28.92%+35.45% 346B
-0.13%-14.97%+9.41%+26.71% 263B
-1.90%-2.72%-2.72%+7.41% 250B
-0.48%-11.65%+39.75%+50.82% 213B
-1.06%-4.23%-14.70%-57.36% 201B
-0.68%-2.65%+25.82%+91.64% 182B
Average -0.53%-4.21%+22.53%+42.53% 354.44B
Weighted average by Cap. -0.42%-3.88%+31.98%+57.01%

Financials

2026 *2027 *
Net sales 192M 165M 156M 142M 265M 18.27B 266M 1.84B 713M 9.31B 721M 705M 29.49B 188M 162M 153M 139M 260M 17.93B 261M 1.81B 699M 9.14B 708M 692M 28.94B
Net income 28.14M 24.21M 22.8M 20.77M 38.87M 2.68B 39.02M 270M 104M 1.36B 106M 103M 4.32B 22.55M 19.4M 18.27M 16.65M 31.15M 2.15B 31.27M 217M 83.69M 1.09B 84.68M 82.84M 3.46B
Net Debt 241M 207M 195M 178M 333M 22.93B 334M 2.31B 894M 11.68B 905M 885M 37.01B 218M 188M 177M 161M 301M 20.74B 302M 2.09B 809M 10.57B 819M 801M 33.48B
Logo DRI Healthcare Trust
DRI Healthcare Trust is a global pharmaceutical royalty monetization company. The Company's portfolio consists of 29 royalty streams on 23 products that treat conditions in a number of therapeutic areas, including oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, as well as lysosomal storage disorders (LSD) and immunology. Its Royalty Assets include Ekterly, Eylea I, Eylea II, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Spinraza, Vonjo I, Vonjo II, Xolair, Zejula, Zytiga, and others. The Ekterly is an oral on-demand therapy for treating attacks associated with Hereditary Angioedema (HAE). The Eylea I is a vascular endothelial growth factor inhibitor initially indicated for the treatment of neovascular wet age-related macular degeneration. Natpara is indicated as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism.
Employees
32
Date Price Change Volume
26-09-09 $17.36 -0.17% 30,136
26-09-08 $17.39 +0.29% 50,612
26-09-04 $17.34 -0.69% 68,428
26-09-03 $17.46 -1.13% 20,755
26-09-02 $17.66 -0.84% 29,534
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
12.57USD
Average target price
16.61USD
Spread / Average Target
+32.17%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DHT.U Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!